Prosecution Insights
Last updated: May 29, 2026
Application No. 18/443,609

NEUROSTIMULATION OF MIXED NERVES

Non-Final OA §102§103
Filed
Feb 16, 2024
Priority
Apr 27, 2018 — AU 2018901410 +2 more
Examiner
EDWARDS, PHILIP CHARLES
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Saluda Medical Pty Ltd.
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
455 granted / 532 resolved
+15.5% vs TC avg
Moderate +15% lift
Without
With
+14.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
27 currently pending
Career history
569
Total Applications
across all art units

Statute-Specific Performance

§101
2.2%
-37.8% vs TC avg
§103
79.1%
+39.1% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
1.9%
-38.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 532 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-9, 12-19, and 21-22 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Min et al. (Pub. No.: US 2016/0175594 A1); hereinafter referred to as “Min”. Regarding claim 1, Min discloses a method of neurostimulation of a mixed nerve comprising a plurality of nerve fibre types (e.g. see abstract, [0065]), the method comprising: delivering to the mixed nerve an electrical stimulus from at least one implantable nominal stimulus electrode, the electrical stimulus being delivered in accordance with a set of stimulus parameters (e.g. see figure 4 step 402, [0065]-[0066]); obtaining from at least one implantable nominal recording electrode a recording of an electrophysiological response evoked by the electrical stimulus (e.g. see figure 4 step 404, [0067]); analysing one or more selected characteristics of the recording to determine whether a recruitment of a first fibre type by the electrical stimulus has occurred (e.g. see figure 4 steps 406, 408, 410, [0068]-[0075]); and based on the recruitment determination, refining the stimulus parameters in a manner to effect selective recruitment of the first fibre type relative to other fibre types of the mixed nerve (e.g. see figure 4 step 412, [0076]-[0078]). Regarding claims 2 and 13, Min discloses the one or more selected characteristics comprise propagation or non-propagation of the recording of the electrophysiological response (e.g. see figure 4 steps 406, 408, 410, [0068]-[0075]. Specifically, [0074] states “Returning to FIG. 4, at 408, the method determines the type of nerve fibers that were activated by the stimulation waveform based on the ECAP frequency data”. Determination of activation of a type of nerve fiber will read on propogation and non-propagation). Regarding claims 3 and 14, Min discloses the stimulus parameters are refined to effect selective recruitment of the first fibre type while further effecting selective non-recruitment or diminished recruitment of at least one other fibre type (e.g. see figure 4 step 412, [0076]-[0078]). Regarding claims 4 and 15, Min discloses the stimulus parameters are varied and a change in morphology of the electrophysiological response with the varied stimulus parameters enables determination of whether recruitment of the first fibre type or the other fibre types has occurred (e.g. see [0069]-[0070], [0098] frequency and amplitude will read on “morphology”, [0098] states “the frequency locations and frequency ranges associated with each cluster, and the amplitudes of the frequency bins therein are generally referred to as a frequency distribution morphology of the ECAP frequency data”). Regarding claims 5, Min discloses the electrophysiological response comprises a neural response without defined peaks (e.g. see [0069]-[0070], the bins are grouped by frequency, frequency doesn’t rely on peak analysis). Regarding claims 6 and 16, Min discloses the varied stimulus parameters comprise a stimulation current (e.g. see [0077]) and the one or more selected characteristics comprise evoked compound action potential (ECAP) shape (e.g. see [0069]-[0070], [0098], frequency and amplitude will read on “shape”), and the method further comprises incrementally increasing the stimulation current (e.g. see [0105], [0107]) and observing a change in the ECAP shape resulting from the incrementally increasing stimulation current (e.g. see figure 8 element 812, 814, 816). Regarding claims 7 and 17, Min discloses observing the change in ECAP morphology at higher amplitudes (e.g. see [0105], [0107]) enables determination that a second fibre type is recruited (e.g. see [0102], “the activity data corresponds to activity for the fiber of interest, such as at least one of the ECAP A-fiber components, ECAP C-fiber components and/or ECAP Aδ fiber components”). Regarding claims 8 and 18, Min discloses the varied stimulus parameters comprise stimulation frequency (e.g. see [0077]), and the one or more selected characteristics comprise an evoked compound action potential (ECAP) shape (e.g. see [0069]-[0070], [0098], frequency and amplitude will read on “shape”), and the method further comprises increasing the stimulation frequency (e.g. see [0105], [0107]) and observing a change in the ECAP shape (e.g. see figure 8 element 812, 814, 816). Regarding claims 9 and 19, Min discloses the method comprises assessing a plurality of the selected characteristics of the recording to determine whether the recruitment of the first fibre type by the electrical stimulus has occurred, the plurality of the selected characteristics of the recording comprising two or more of: one or more electrophysiological response peak positions (e.g. see [0098]); one or more electrophysiological response peak amplitudes (e.g. see [0098]); number of electrophysiological response peaks (e.g. see [0098]) with increasing stimulus current (e.g. see [0105], [0107]); response properties of the electrophysiological response to varying stimulus frequencies (e.g. see [0105], [0107]). Regarding claim 12, Min discloses the steps (see the rejection for claim 1 above) and further discloses a control unit (e.g. see [0088], figure 7 element 702). Regarding claims 21 and 22, Min discloses the invention (see the rejection for claims 1 and 12 above) and further discloses issuing an alert (e.g. see [0088], figure 7 elements 710 and 742. [0088] discloses “speaker 710 provides an audible warning (e.g., sounds and tones 742) to the user”) Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 10, 11, and 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Min in view of Parker et al. (Pub. No.: US 2014/0236257 A1); hereinafter referred to as “Parker”. Regarding claims 10, 11, and 20, Min discloses determining whether the recruitment of the first fibre type by the electrical stimulus has occurred (e.g. see figure 4 steps 406, 408, 410, [0068]-[0075]) but is silent as to recording of the evoked electrophysiological response comprises a myoelectric response in addition to a neural response and assessing the one or more selected characteristics of each of the myoelectric response and the neural response. Parker teaches it is known to use such a modification as set forth in [0054], [0079], [0088] (Note: The examiner’s understanding is myoelectric is EMG) to determine the allowable dynamic range of stimulation which is available to the patient, and further may be used to verify that ongoing stimuli are delivering a desired therapy [0089]. It would have been obvious to one having ordinary skill in the art at the time the invention was made to use EMG in addition to ECAP sensing as taught by Parker in the system/method of Min, since said modification would provide the predictable results of determining the allowable dynamic range of stimulation which is available to the patient, and further may be used to verify that ongoing stimuli are delivering a desired therapy. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILIP C EDWARDS whose telephone number is (571)270-1804. The examiner can normally be reached Mon-Fri, 9:00-5:00 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /P.C.E/Examiner, Art Unit 3792 /UNSU JUNG/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Feb 16, 2024
Application Filed
Apr 07, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636497
SYSTEMS AND METHODS FOR IMPROVING SLEEP DISORDERED BREATHING
4y 2m to grant Granted May 26, 2026
Patent 12629516
DEVICE AND SYSTEM FOR REAL-TIME GAIT MODULATION AND METHODS OF OPERATION THEREOF
3y 7m to grant Granted May 19, 2026
Patent 12611545
DEVICE AND METHOD FOR UNATTENDED TREATMENT OF A PATIENT
2y 9m to grant Granted Apr 28, 2026
Patent 12569678
MULTI-ELECTRODE MINIATURE ELECTRICAL STIMULATION SYSTEM AND TREMOR RELIEF WRISTBAND
3y 0m to grant Granted Mar 10, 2026
Patent 12521029
SYSTEM AND METHOD FOR MULTIPLEXING AN OPTICAL SENSOR
2y 11m to grant Granted Jan 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
99%
With Interview (+14.6%)
2y 5m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 532 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month